Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction

Journal of Nuclear Cardiology

Volumn 5, Issue 6, 1998, Pages 558-566

  Di Carli, Marcelo F ^a,b,c   Asgarzadie, Farbod ^a   Schelbert, Heinrich R ^a   Brunken, Richard C ^a   Rokhsar, Sepehr ^a   Maddahi, Jamshid ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Left ventricular dysfunction; Myocardial perfusion; Positron emission tomography; Tissue viability

Indexed keywords

ADENOSINE; AMMONIA; DEOXYGLUCOSE; DIPYRIDAMOLE; FLUORINE 18; NITROGEN 13; TRACER;

ADULT; AGED; ARTICLE; BLOOD FLOWMETRY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; FLOW MEASUREMENT; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REGIONAL PERFUSION; REVASCULARIZATION; TISSUE INJURY; VASODILATATION;

EID: 0032445866     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(98)90109-X     Document Type: Article

References (26)

1. Tillisch J, Brunken R, Marshall RC, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
2. Tamaki N, Kawamoto M, Tadamura E, Magata Y, Yonekura Y, Nohara R, et al. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation 1995;91:1697-705.
3. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple W. Quantitative planar rest-redistribution TI-201 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;86:1630-41.
4. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
5. Ohtani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990;66:394-99.
6. Vanoverschelde JLJ, Gerber BL, D'Hont AM, De Kock M, Dion R, Wijns W, et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization. Role of lowdose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995;92(suppl II):37-44.
7. Porenta G, Kuhle W, Czernin J, Ratib O, Brunken RC, Phelps ME, et al. Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. J Nucl Med 1992;33(9):1628-36.
8. Bonow RO, Dilsizian V, Cuoccolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation 1991;83:26-37.
9. Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson RC, Henze E, et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1981;64:766-78.
10. Maddahi J, Schelbert H, Brunken R, Di Carli M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med 1994;35:707-15.
11. Marwick TH, Nemec JJ, Lafont A, Salcedo EE, Maclntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 1992;69:854-9.
12. Di Carli M, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-44.
13. Eitzman D, Al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, et al. Clinical outcome of patients with advanced coronary artery dis-ease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20(3):559-65.
14. Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993;22:984-97.
15. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73(8):527-33.
16. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
17. Delbeke D, Lorenz CH, Votaw JR, Silveira ST, Frist WH, Atkinson JB, et al. Estimation of left ventricular mass and infarct size from nitrogen13-ammonia PET images based on pathological examination of explanted human hearts. J Nucl Med 1993;34:826-33.
18. Geltman EM, Biello D, Welch MJ, Ter-Pogossian MM, Roberts R, Sobel BE. Characterization of nontransmural myocardial infarction by positron-emission tomography. Circulation 1982;65:747-55.
19. Vom Dahl J, Eitzman DT, Al-Aouar ZR, Kanter HL, Hicks RJ, Deeb M, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-66.
20. Di Carli MF, Maddahi J, Rokhsar S, Schelbert HR, Brunken RC. Longterm survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. Circulation 1997;96:I-434.
21. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 1977;56:786-94.
22. Reimer KA, Jennings RB. The wavefront phenomenon of ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40:633-44.
23. Gewirtz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994;23:851-9.
24. Bolli R. Myocardial 'stunning' in man. Circulation 1992;86:1671-91.
25. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-23.
26. Marinho NV, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996;93:737-44.